Introduction {#s1}
============

Several studies have revealed that a deficiency of vitamin D would increase the risk of tuberculosis \[[@B1],[@B2]\], and vitamin D from food or exposure to sunlight would benefit the treatment of tuberculosis \[[@B3]-[@B5]\]. 1,25-dihydroxyvitamin D~3~, which is the active form of vitamin D, was activated by 1α-hydoxylase that was expressed by macrophages and other immune cells and bind to the vitamin D receptor (VDR) for to modulate the immune system in fighting with *Mycobacterium* infection \[[@B6]\].

In recent years, the anti-bacteria effects of Vitamin D in the human immune system have been explored extensively \[[@B7]\]. Meanwhile, host-genetic susceptibility was considered contribute to the risk of tuberculosis development. The VDR gene is located in the chromosomal 12q13 region, and, in the last decade, studies have focused on the association between genetic variants of the VDR gene and tuberculosis risk based on the hypothesis that genetic alterations of the VDR gene might lead to important defects in gene activation, that could affect immune function. For instance, deleterious mutations in the VDR gene cause 1, -25-dihydroxivitamin D resistant rickets, a rare monogenetic disease \[[@B8]\]. Four potentially functional single nucleotide polymorphisms (SNPs) of the VDR gene (ApaI, SNP ID: rs7975232; BsmI, SNP ID: rs1544410; FokI, SNP ID: rs2228570; and TaqI, SNP ID: rs731236) have been main focus in relation to the risk of tuberculosis compared to other SNPs. Changes in the amino acid sequence or transcriptional activity might be induced by these four mutations; therefore, these mutations could affect an individual's susceptibility to tuberculosis.

Due to underpowered design or small study sample size, previous studies have not reached a consensus regarding the association between the VDR gene variants and tuberculosis risk \[[@B9]-[@B11]\]. A previous meta-analysis conducted by Gao et al reported marginal, significant associations of the ApaI and TaqI polymorphisms with tuberculosis risk \[[@B12]\], but this finding needs to be validated in a larger pooled sample size. After the results reported by Gao et al, nearly ten research studies were conducted to elucidate the relationship between the VDR gene polymorphisms and tuberculosis risk, and their results were also inconsistent. Additionally, studies of European ethnicity \[[@B13],[@B14]\] were not included in the analysis in the previous meta-report. Thus, because previous results were inconsistent and more ethnic background needed to be added, it was necessary to carry out this meta-analysis on the relationship between hot spot variants of the VDR gene and the risk of tuberculosis.

Methods {#s2}
=======

Search protocol and eligibility of enrolled studies {#s2.1}
---------------------------------------------------

We searched two databases for association studies of VDR gene polymorphisms and tuberculosis: PubMed and Web of Science. We conducted the search from March 18^th^ 2013 to April 1^st^ 2013, and all the searched results were finally updated on April 1^st^ 2013. All articles catalogued before April 1^st^ 2013 were considered. Two medical subject headings (Mesh), "Tuberculosis" and "Vitamin D receptor", were used to search for related articles, and qualified articles were included according to the following criteria: (1) the original articles were published in English; (2) the studies had a case-control design and were conducted in human beings; and (3) the articles contained available genotyping information on VDR gene polymorphisms (ApaI, BsmI, FokI and TaqI were the four SNPs that were analyzed in this article). Two independent investigators were employed to search the related articles according to the above criteria.

Data extraction {#s2.2}
---------------

The two investigators independently extracted data and reached a consensus on all of the items. If the two investigators generated different results, they would check the data again and finally reach a consensus. An expert would be invited to the discussion if they could not reach an agreement. Data extracted from the selected articles included the first author's name, year of publication, country of origin, ethnicity, number of cases and controls, diagnosis method of cases and the selection of controls.

Statistical analysis {#s2.3}
--------------------

The association between the four polymorphisms and risk of tuberculosis for each study was estimated by the odds ratio (OR) and 95% confidence interval (CI). A χ^2^-test-based *Q* statistic test was performed to assess the between study heterogeneity, and *P*\<0.05 was considered a significant level. A fixed-effect model by the Mantel--Haenszel method and a random-effect model by the DerSimonian and Laird method were adopted for combining data. When the P value of heterogeneity was \<0.05, then a random-effect model was employed. Otherwise, the fixed-effect model was adopted throughout the analyses. These two models provided similar results when heterogeneity between studies was absent; otherwise, a random-effect model was more appropriate. Bonferroni correction was adopted for multiple comparisons.

Heterozygote and variant homozygote of each SNP was compared with the wild-type homozygote to estimate the risk of tuberculosis. Then, a dominant model, that combined variant homozygote and heterozygote genotypes, was established to calculate the risk of tuberculosis, versus the wild-type homozygote. Meanwhile, heterozygote and wild-type homozygote genotypes of each SNP were also combined as a recessive model to evaluate the risk of tuberculosis, versus the variant homozygote.

Stratification analyses were performed based on ethnicity and region, and a meta regression was used to illustrate the potential reasons for heterogeneity between the studies. Inverted funnel plots, an Egger's test and a Horbold-Egger's test were used to assess publication bias \[[@B15]\]. Meta-analysis was carried out using Review Manager (V5.2, The Cochrane Collaboration, Oxford, UK); meanwhile, Egger's test for publication bias was conducted using Stata software (V10.0, Stata, College Station, TX, USA), and evaluations were made assuming a two-sided test with a significance level of 0.05.

Results {#s3}
=======

Characteristics of enrolled studies {#s3.1}
-----------------------------------

A flow chart of the inclusion and exclusion procedures of the articles is shown in [Figure 1](#pone-0083843-g001){ref-type="fig"}. According to the inclusion criteria, twenty nine qualified case-control studies were included in the final analysis \[[@B10],[@B11],[@B13],[@B14],[@B16]-[@B40]\]. Seventeen studies were conducted in Asia, seven in Africa and the remaining five were conducted in Europe and America. The basic information of the enrolled studies was listed in [Table 1](#pone-0083843-t001){ref-type="table"}. A total of 6179 tuberculosis cases were obtained in the twenty nine studies, including 5306 (85.9%) with pulmonary tuberculosis, 383 (6.2%) with extra pulmonary tuberculosis, and 490 with (7.9%) tuberculosis without a specific disease origination part of the body. The corresponding controls for the tuberculosis cases were 6585. Meanwhile, the HIV (Human Immunodeficiency Virus) status was not available in eleven (37.9%) studies. In this meta-analysis, SNPs (ApaI and BsmI) near the 3′ untranslated region (UTR) and SNPs (FokI and TaqI) in the coding region were evaluated. The TaqI polymorphism was the most evaluated SNP in the twenty five case-control studies, while FokI was found in twenty three studies, BsmI was found in eighteen studies and ApaI was found in fifteen studies.

![Flow chart of study inclusion.](pone.0083843.g001){#pone-0083843-g001}
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###### Basic information of qualified cases-control studies on vitamin D receptor gene polymorphisms for tuberculosis.

  Year   First Author     Country                         Ethnicity   Tuberculosis                                                                                                       Controls                                                   HIV status                                           SNPs
  ------ ---------------- ------------------------------- ----------- ------------------------------------------------------------------ ----- ----------------------------------------- --------------------------------------------------- ------ ---------------------------------------------------- ------------------------
  1999   Bellamy          Gambia                          African     Pulmonary tuberculosis                                             408   AFB smear                                 Male donors                                         414    All tested negative                                  TaqI
  2000   Selvaraj         India                           Asian       Spinal tuberculosis                                                66    Culture and X-ray                         Spouses of TB contacts                              80     Not available                                        TaqI
  2000   Wilkinson        India                           Asian       Pulmonary tuberculosis(27) and military tuberculosis (64)          91    Biopsy or culture                         Tuberculosis contacts with no TB                    116    All tested negative                                  FokI, TaqI
  2002   Delgado          Cambodia                        Asian       Pulmonary tuberculosis                                             358   AFB smear                                 Control with no signs or symptoms of TB             106    All tested negative                                  TaqI
  2002   Fibla            Spain                           European    Pulmonary tuberculosis(48) and extra pulmonary tuberculosis (18)   66    Culture and X-ray                         Healthy persons                                     136    Cases positive, Controls negative                    BsmI
  2003   Selvaraj         India                           Asian       Pulmonary tuberculosis                                             120   Culture                                   patient contacts                                    80     Not available                                        FokI, ApaI, BsmI
  2004   Bornman          Gambia, Guinea-Bissau, Guinea   African     Pulmonary tuberculosis                                             417   AFB or culture                            healthy community control subjects                  722    Cases (12.5%),controls(6.8%)                         FokI, ApaI, TaqI, BsmI
  2004   Fitness          Malawi                          African     Tuberculosis                                                       386   AFB smear, culture and histology          age, sex and area of residence matched with cases   624    HIV positive in 67.6% cases and 13.1% controls       ApaI, TaqI, BsmI
  2004   Liu              China                           Asian       Pulmonary tuberculosis                                             120   AFB smear, culture and X-ray              normal controls                                     240    All reported negative                                FokI, TaqI
  2004   Roth             Peru                            American    Pulmonary tuberculosis                                             103   AFB smear                                 Two healthy controls,1PPD+ and 1PPD-                206    All reported negative                                FokI, TaqI
  2004   Selvaraj         India                           Asian       Spinal tuberculosis patients                                       64    X-ray and Clinical criteria               Normal healthy controls                             103    Not available                                        FokI, ApaI, TaqI, BsmI
  2006   Lombard          Venda                           African     Pulmonary and meningeal tuberculosis                               104   AFB smear                                 Healthy controls with no history of TB              117    All reported negative                                FokI, ApaI, TaqI, BsmI
  2007   Babb             South Africa                    African     Pulmonary tuberculosis                                             249   AFB smear and X-Ray                       No clinical history or symptoms of TB               352    All reported negative                                FokI, ApaI, TaqI
  2007   [Olesen]{.ul}    Guinea-Bissau                   African     Pulmonary tuberculosis                                             321   AFB smear and clinical critiera           Healthy controls                                    347    HIV positive in 33% cases and negative in controls   FokI, ApaI, TaqI, BsmI
  2007   Soborg           Tanzanian                       African     Pulmonary tuberculosis                                             443   Culture                                   Culture negative                                    426    HIV positive in 44% cases and 18% controls           FokI, ApaI, TaqI
  2007   Wilbur           Paraguay                        American    Pulmonary tuberculosis                                             54    Clinical symptoms, PPD test               No symptoms                                         124    Not available                                        FokI, TaqI
  2008   Selvaraj         India                           Asian       Pulmonary tuberculosis                                             51    AFB smear and culture                     Normal healthy subjects                             60     All reported negative                                FokI, ApaI, TaqI, BsmI
  2009   Alagarasu        India                           Asian       Pulmonary (190) and extra pulmonary tuberculosis (31)              221   AFB smear, clinical criteria and X-ray    Healthy controls                                    146    Cases(51%),Controls(0)                               FokI, ApaI, TaqI, BsmI
  2009   Merza            Iran                            Asian       Pulmonary Tuberculosis                                             117   AFB smear and X-ray                       Healthy individuals                                 60     Not available                                        FokI, BsmI
  2009   Selvaraj         India                           Asian       Pulmonary tuberculosis                                             65    Clinical symptom, AFB smear and culture   Healthy subjects                                    60     All reported negative                                FokI, ApaI, TaqI, BsmI
  2009   Vidyarani        India                           Asian       Pulmonary tuberculosis                                             40    AFB smear and culture                     Normal healthy subjects                             49     Not available                                        FokI, ApaI, TaqI, BsmI
  2010   Banoei           Iran                            Asian       Pulmonary tuberculosis                                             60    Confirmed in Massih Daneshvari Hospital   Healthy subjects                                    62     All reported negative                                FokI, TaqI, BsmI
  2010   Marashian        Iran                            Asian       Pulmonary tuberculosis                                             164   AFB smear and X-ray                       Healthy People                                      50     Not available                                        FokI, ApaI, TaqI, BsmI
  2010   Zhang            China                           Asian       Spinal tuberculosis                                                110   Postoperative pathology                   Healthy subjects                                    102    All reported negative                                FokI
  2011   Ates             Turkey                          European    Pulmonary (98) and extra pulmonary tuberculosis (30)               128   AFB and Culture                           Healthy subjects                                    80     Not available                                        FokI, TaqI, BsmI
  2011   Sharma           India                           Asian       Pulmonary tuberculosis                                             992   AFB smear and Culture                     Healthy subjects                                    1183   Not available                                        FokI, ApaI, TaqI, BsmI
  2011   Singh            India                           Asian       Pulmonary tuberculosis                                             101   AFB smear or culture                      healthy controls                                    225    All reported negative                                FokI, TaqI, BsmI
  2012   Rathored         India                           Asian       MDR tuberculosis and drug sensitive pulmonary tuberculosis         692   AFB smear and culture                     healthy volunteers                                  205    Not available                                        FokI, TaqI, BsmI
  2013   Alexandra        Romania                         European    Pulmonary tuberculosis                                             68    Not available                             unrelated healthy individuals                       110    Not available                                        ApaI, TaqI

^a^ AFB, Acid-fast bacilli; HIV, human immunodeficiency virus; MDR, multi-drug resistance for isoniazide and rifampicin; PPD, purified protein derivative; SNPs, single nucleotide polymorphism; TB, tuberculosis.

Quantitative synthesis {#s3.2}
----------------------

In [Table 2](#pone-0083843-t002){ref-type="table"}, four SNPs and their relationship to the risk of tuberculosis were evaluated by four types of comparisons: (1), heterozygote genotype versus wild-type homozygote genotype; (2), variant homozygote genotype versus wild-type homozygote genotype; (3), dominant model: variant homozygote genotype combined with a heterozygote genotype versus wild-type homozygote genotype; and (4), recessive model: variant homozygote genotype versus heterozygote and wild-type homozygote genotypes). As shown in [Table 2](#pone-0083843-t002){ref-type="table"}, when the P value of the heterogeneity test between the studies was less than 0.05, a random-effect model was used to calculate the odds ratios and 95% confidence interval. Otherwise, a fixed-effect model was adopted.

10.1371/journal.pone.0083843.t002

###### Summary of VDR gene genotypes on the risk of tuberculosis in different ethnicities.

  SNP    Ethnicity                                        Cases                            Controls                         HT vs. WT Homo                                                  ^[e](#ngtab2.1){ref-type="table-fn"}^ *P*-value   VR homo vs. WT Homo                                             ^[e](#ngtab2.1){ref-type="table-fn"}^ *P*-value   Dominant model^[a](#ngtab2.2){ref-type="table-fn"}^         ^[e](#ngtab2.1){ref-type="table-fn"}^ *P*-value   Recessive model^[b](#ngtab2.3){ref-type="table-fn"}^            ^[e](#ngtab2.1){ref-type="table-fn"}^ *P*-value
  ------ ------------------------------------------------ ---------- ---------- ---------- ---------- ---------- ---------- --------------------------------------------------------------- ------------------------------------------------- --------------------------------------------------------------- ------------------------------------------------- ----------------------------------------------------------- ------------------------------------------------- --------------------------------------------------------------- -------------------------------------------------
  ApaI                                                    AA         Aa         aa         AA         Aa         aa                                                                                                                                                                                                                                                                                                                                                                                                                           
         Total                                            **1028**   **1423**   **540**    **1265**   **1720**   **646**    1.00 \[0.84, 1.20\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 0.88 \[0.65, 1.19\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 0.97 \[0.81, 1.16\] ^[c](#ngtab2.4){ref-type="table-fn"}^   1                                                 0.89 \[0.78, 1.02\]                                             0.4
         ES Asians                                        0          0          0          0          0          0          NA                                                                                                                NA                                                                                                                NA                                                                                                            NA                                                              
         SW Asians                                        461        530        137        425        567        120        0.91 \[0.67, 1.25\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 0.94 \[0.71, 1.26\]                                             1                                                 0.92 \[0.69, 1.24\] ^[c](#ngtab2.4){ref-type="table-fn"}^   1                                                 1.01 \[0.77, 1.32\]                                             1
         Africans                                         548        844        403        813        1095       501        1.06 \[0.82, 1.36\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 0.92 \[0.64, 1.32\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 1.03 \[0.79, 1.34\] ^[c](#ngtab2.4){ref-type="table-fn"}^   1                                                 0.91 \[0.77, 1.07\]                                             0.92
         Americans                                        0          0          0          0          0          0          NA                                                                                                                NA                                                                                                                NA                                                                                                            NA                                                              
         Europeans                                        19         49         0          27         58         25         1.20 \[0.60, 2.42\]^[d](#ngtab2.5){ref-type="table-fn"}^        1                                                 0.00 \[0.00, 0.06\]^[d](#ngtab2.5){ref-type="table-fn"}^        0.0004                                            0.84 \[0.42, 1.66\]^[d](#ngtab2.5){ref-type="table-fn"}^    1                                                 0.02 \[0.00, 0.41\]^[d](#ngtab2.5){ref-type="table-fn"}^        0.04
  BsmI                                                    BB         Bb         bb         BB         Bb         bb                                                                                                                                                                                                                                                                                                                                                                                                                           
         Total                                            **647**    **1449**   **1163**   **583**    **1428**   **1426**   1.07 \[0.82, 1.41\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 0.90 \[0.64, 1.26\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 0.99 \[0.75, 1.31\] ^[c](#ngtab2.4){ref-type="table-fn"}^   1                                                 0.86 \[0.72, 1.03\] ^[c](#ngtab2.4){ref-type="table-fn"}^       0.36
         ES Asians                                        0          0          0          0          0          0          NA                                                                                                                NA                                                                                                                NA                                                                                                            NA                                                              
         SW Asians                                        540        935        478        438        726        419        1.09 \[0.77, 1.53\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 0.88 \[0.58, 1.33\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 0.99 \[0.70, 1.40\] ^[c](#ngtab2.4){ref-type="table-fn"}^   1                                                 0.82 \[0.63, 1.06\] ^[c](#ngtab2.4){ref-type="table-fn"}^       0.48
         Africans                                         69         410        633        125        584        929        1.33 \[0.96, 1.84\]                                             0.32                                              1.35 \[0.98, 1.86\]                                             0.24                                              1.34 \[0.98, 1.82\]                                         0.28                                              1.06 \[0.91, 1.24\]                                             1
         Americans                                        0          0          0          0          0          0          NA                                                                                                                NA                                                                                                                NA                                                                                                            NA                                                              
         Europeans                                        38         104        52         20         118        78         0.47 \[0.24, 0.91\]                                             0.08                                              0.34 \[0.07, 1.58\] ^[c](#ngtab2.4){ref-type="table-fn"}^       0.68                                              0.41 \[0.22, 0.76\]                                         0.02                                              0.62 \[0.24, 1.58\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1
  FokI                                                    FF         Ff         ff         FF         Ff         Ff                                                                                                                                                                                                                                                                                                                                                                                                                           
         Total                                            **2116**   **1433**   **369**    **2160**   **1566**   **337**    0.89 \[0.76, 1.05\] ^[c](#ngtab2.4){ref-type="table-fn"}^       0.64                                              1.24 \[0.91, 1.70\] ^[c](#ngtab2.4){ref-type="table-fn"}^       0.68                                              0.94 \[0.79, 1.11\] ^[c](#ngtab2.4){ref-type="table-fn"}^   1                                                 1.36 \[1.14, 1.62\]                                             0.0028
         ^[f](#ngtab2.6){ref-type="table-fn"}^ES Asians   45         106        79         111        167        64         1.52 \[0.99, 2.33\]                                             0.20                                              2.55 \[1.55, 4.19\]                                             0.0008                                            1.81 \[1.21, 2.71\]                                         0.016                                             1.97 \[1.32, 2.93\]                                             0.0032
         SW Asians                                        1025       707        150        708        601        60         0.71 \[0.55, 0.93\] ^[c](#ngtab2.4){ref-type="table-fn"}^       0.04                                              1.37 \[0.74, 2.51\]                                             1                                                 0.77 \[0.58, 1.01\] ^[c](#ngtab2.4){ref-type="table-fn"}^   0.24                                              1.58 \[0.94, 2.65\] ^[c](#ngtab2.4){ref-type="table-fn"}^       0.32
         Africans                                         944        509        71         1211       641        95         1.04 \[0.90, 1.20\]                                             1                                                 0.96 \[0.70, 1.33\]                                             1                                                 1.03 \[0.89, 1.18\]                                         1                                                 0.95 \[0.69, 1.31\]                                             1
         Americans                                        44         51         59         95         120        110        0.89 \[0.51, 1.54\]                                             1                                                 0.84 \[0.35, 1.98\]                                             1                                                 0.92 \[0.54, 1.56\]                                         1                                                 1.20 \[0.74, 1.94\]                                             1
         Europeans                                        58         60         10         35         37         8          0.98 \[0.54, 1.76\] ^[d](#ngtab2.5){ref-type="table-fn"}^       1                                                 0.75 \[0.27, 2.09\] ^[d](#ngtab2.5){ref-type="table-fn"}^       1                                                 0.94 \[0.53, 1.65\] ^[d](#ngtab2.5){ref-type="table-fn"}^   1                                                 0.76 \[0.29, 2.02\] ^[d](#ngtab2.5){ref-type="table-fn"}^       1
  TaqI                                                    TT         Tt         tt         TT         Tt         tt                                                                                                                                                                                                                                                                                                                                                                                                                           
         Total                                            **2553**   **1842**   **412**    **2864**   **2082**   **471**    1.05 \[0.91, 1.20\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 1.03 \[0.77, 1.37\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 1.04 \[0.90, 1.21\] ^[c](#ngtab2.4){ref-type="table-fn"}^   1                                                 0.97 \[0.76, 1.24\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1
         ES Asians                                        430        42         6          299        42         5          0.79 \[0.48, 1.32\]                                             1                                                 1.33 \[0.37, 4.76\]                                             1                                                 0.86 \[0.53, 1.39\]                                         1                                                 1.37 \[0.38, 4.91\]                                             1
         SW Asians                                        712        735        233        710        592        197        1.23 \[0.97, 1.57\] ^[c](#ngtab2.4){ref-type="table-fn"}^       0.36                                              1.27 \[0.76, 2.10\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1                                                 1.26 \[0.95, 1.67\] ^[c](#ngtab2.4){ref-type="table-fn"}^   0.44                                              1.08 \[0.73, 1.60\] ^[c](#ngtab2.4){ref-type="table-fn"}^       1
         Africans                                         1234       910        155        1554       1272       233        0.89 \[0.79, 1.00\]                                             0.2                                               0.86 \[0.59, 1.24\] **^[c](#ngtab2.4){ref-type="table-fn"}^**   1                                                 0.88 \[0.79, 0.98\]                                         0.12                                              0.89 \[0.62, 1.27\] **^[c](#ngtab2.4){ref-type="table-fn"}^**   1
         Americans                                        112        38         4          228        89         6          0.92 \[0.56, 1.49\]                                             1                                                 1.69 \[0.48, 5.96\]                                             1                                                 0.94 \[0.58, 1.51\]                                         1                                                 1.56 \[0.46, 5.33\]                                             1
         Europeans                                        65         117        14         73         87         30         1.70 \[0.61, 4.74\] **^[c](#ngtab2.4){ref-type="table-fn"}^**   1                                                 0.47 \[0.21, 1.04\]                                             0.24                                              1.35 \[0.87, 2.07\]                                         0.72                                              0.20 \[0.01, 6.66\] **^[c](#ngtab2.4){ref-type="table-fn"}^**   1

^a^ Dominant model: the combination of variant homozygote genotype and heterozygote genotype versus the wild-type homozygote.

^b^ Recessive model: variant homozygote versus the combination of heterozygote genotype and wild-type homozygote genotype.

^c^ Random-effect model was used because of the *P*-value for the heterogeneity test was \<0.05.

^d^ Heterogeneity can not be calculated due to one study.

^e^ *P*-value was adjusted by Bonferroni correction, as multiple comparison was done at four times for each SNPs and in subgroups of different ethnicities.

^f^ Data were available from two Chinese studies.

Abbreviations: CI, confidence interval; ES, East and Southeast; Ht, heterozygote; OR, odds ratio; NA, not available; SNP, single-nucleotide polymorphism; SW, South and West; VDR, vitamin D receptor; VR Homo, variant homozygote; WT Homo, wide-type homozygote.

Of the seventeen studies that were conducted in Asia, two were form China, one was from Cambodia, and the remainder originated from India and Iran. Because the geographical differences might contribute to the genetic diversity, we classified the studies into two groups: East and Southeast Asia (China and Cambodia) and South and West Asia (India and Iran). Additionally, seven African studies were conducted in the sub-Saharan region. As a result, we classified the enrolled studies into five subgroups based on ethnicity and region for the subgroup analysis. The five subgroups included East and Southeast Asians, South and West Asians, Africans, Europeans and Americans.

Of the four types of comparisons, we found that only the variant homozygous genotype of FokI polymorphism was associated with a significantly increased risk of tuberculosis when compared to the heterozygous and wild type homozygous genotypes (OR~*recessive*~=1.36, 95%CI: 1.14-1.62, *P* ~*bonferroni*~=0.0028; heterogeneity test: χ^2^=33.28, *P*=0.06) ([Figure 2](#pone-0083843-g002){ref-type="fig"}). Furthermore, when stratifying the different ethnicities (there were only two Chinese studies conducted in East and Southeast Asians), a significant association of recessive model was only found in Chinese (OR~*recessive*~=1.97, 95%CI: 1.32-2.93, *P* ~*bonferroni*~=0.0032; heterogeneity test: χ^2^=0.24, *P*=0.62) ([Figure 3](#pone-0083843-g003){ref-type="fig"}). Also in the same stratification, the variant homozygote of the FokI polymorphism significantly increased the risk of tuberculosis by 1.55 fold when compared to the wild type (OR=2.55, 95%CI: 1.55-4.19, *P* ~*bonferroni*~=0.0008; heterogeneity test: χ^2^=0.15, *P*=0.70), and the dominant model of the FokI polymorphism was also significantly increased tuberculosis risk by 0.81 fold (OR~*dominat*~=1.81, 95%CI: 1.21-2.71, *P* ~*bonferroni*~=0.016; heterogeneity test: χ^2^=0.13, *P*=0.72). The protective effect of heterozygote of the FokI polymorphism was in marginal significance in South and West Asians (*P*=0.04). The forest plots of the VDR gene FokI polymorphism (recessive model) in South and West Asians, Africans and Americans showed no significant associations ([Figure 4](#pone-0083843-g004){ref-type="fig"}, [5](#pone-0083843-g005){ref-type="fig"} and [6](#pone-0083843-g006){ref-type="fig"}). Because only one study was found for FokI in Europe, that forest plot was not implemented.

![Forest plot of the recessive model of the VDR gene FokI polymorphism on the risk of tuberculosis.](pone.0083843.g002){#pone-0083843-g002}

![Forest plot of the recessive model of the VDR gene FokI polymorphism on the risk of tuberculosis in Chinese.](pone.0083843.g003){#pone-0083843-g003}

![Forest plot of the recessive model of the VDR gene FokI polymorphism on the risk of tuberculosis in Indians and Iranians.](pone.0083843.g004){#pone-0083843-g004}

![Forest plot of the recessive model of the VDR gene FokI polymorphism on the risk of tuberculosis in Africans.](pone.0083843.g005){#pone-0083843-g005}

![Forest plot of the recessive model of the VDR gene FokI polymorphism on the risk of tuberculosis in Americans.](pone.0083843.g006){#pone-0083843-g006}

The other three SNPs of the VDR gene showed no notable associations with tuberculosis risk in the pooled samples. However, stratification of ethnicities revealed some evidence of tuberculosis risk for the other three SNPs.

For the BsmI polymorphism in the European population, the variant homozygote and heterozygote genotypes were associated with a significantly decreased risk of tuberculosis when compared to the wild type homozygote (OR~*dominant*~=0.41, 95%CI: 0.22-0.76, *P* ~*bonferroni*~=0.02; heterogeneity test: χ^2^=2.59, *P*=0.11). Although the heterozygote of the BsmI polymorphism decreased the risk of tuberculosis by 0.53-fold when compared to the wild type homozygote (OR=0.47, 95%CI: 0.24-0.91; *P* ~*bonferroni*~=0.08; heterogeneity test: χ^2^=1.17, *P*=0.28), the Bonferroni correction showed no significance.

For the TaqI polymorphism in the African population, the variant homozygote and heterozygote genotypes reduced the risk of tuberculosis when compared to the wild type homozygote by marginal significance (OR~*dominant*~=0.88, 95%CI: 0.79-0.98, *P* ~*bonferroni*~=0.12; heterogeneity test: χ^2^=8.51, *P*=0.20). Also, the heterozygote of the TaqI polymorphism reduced the risk of tuberculosis by 0.11 fold when compared to the wild type homozygote (OR=0.89, 95%CI: 0.79-1.00; *P* ~*bonferroni*~=0.2; heterogeneity test: χ^2^=1.17, *P*=0.28). However, the adjusted *P*-values of the above results showed no significance by Bonferroni correction.

Because only one study was conducted in the European population for the ApaI polymorphism, the heterogeneity and pooled ORs could not be calculated.

Meta regression was adopted to illustrate the potential reasons for heterogeneity between the studies if the *P*-value of that heterogeneity was less than 0.05. However, the *P*-value of the heterogeneity test for the significant association (recessive model of FokI polymorphism) exceeded 0.05. Therefore, we did not perform further meta-regression.

Publication bias {#s3.3}
----------------

In this meta-analysis, a Funnel plot, Egger's test and Horbold-Egger's test was used to evaluate the potential publication bias of the enrolled studies. For the significant result of the FokI recessive model, the Egger's test (*t*=0.51, *P*=0.614) showed no evidence of publication bias. However, the funnel plot of the FokI recessive model suggested some asymmetry that might be induced by small sample sizes ([Figure 7](#pone-0083843-g007){ref-type="fig"}). However, the Horbold-Egger's test supported the result of Egger's test that suggested that the publication bias induced by small sample sizes was limited (*t*=0.48, *P*=0.633).

![Funnel plot of the recessive model of the VDR gene FokI polymorphism on the risk of tuberculosis, Egger\'s Test: *t*=0.51, *P*=0.614.\
log, logarithms; SE, standard error.](pone.0083843.g007){#pone-0083843-g007}

Discussion {#s4}
==========

In this meta-analysis of the relationship between the VDR gene polymorphisms and the risk of tuberculosis, we found that the FokI SNP in the recessive model (ff vs. Ff/FF) significantly increased the risk of tuberculosis, and the risk effect was found in the Chinese population. The other three SNPs variants were not linked to any significant risk or protective effect on tuberculosis in the total population. However, in the stratification of different ethnicities, we found that the dominant model of BsmI SNP generated a protective effect on tuberculosis in the European population.

Because the frequency of minor alleles of each SNP of VDR gene was commonly more than 0.01 in the different populations based on the HapMap data ([[http://hapmap.ncbi.nlm.nih.gov/]{.ul}](http://hapmap.ncbi.nlm.nih.gov/)), the four SNPs are valuable for tuberculosis susceptibility research in different ethnic backgrounds. Genetic alterations of the VDR gene may lead to changes in gene activation or in VDR protein structure, and these changes could affect the cellular function of 1,25-dihydroxyvitamin D3. Additionally, VDR gene polymorphisms could be linked to each other and to other unidentified genes, which could also be important for tuberculosis risk.

The FokI SNP was located within the exon 2 of the VDR gene, and evidence of FokI functionality has already been obtained \[[@B41]\]. Results from transcriptional activation studies in transfected HeLa cells using a reporter construct under the control of a short portion of the rat 24-hydroxylase gene promoter region (-291-+9) containing a vitamin D responsive element (VDRE) suggested that the short 424 amino acid VDR protein variant (corresponding with the C-allele or ''big F'' allele) would be more active than the long 427 aa variant. Because the luciferase activities of transfected HeLa cells that containing different variants of FokI increased by 19.5- (ff) and 11.2-fold (FF), respectively. Thus, a 1.7-fold relative difference was observed between the two variants. Thus, the f allele of FokI might decrease the activity of the VDR protein and deter the binding of active vitamin D and VDR. Our results on the FokI polymorphism were in accordance with a previously conducted meta-analysis which indicated that the f allele in a recessive model would increase the risk of tuberculosis, and the same effect was found in the Chinese population but not for other ethnicities \[[@B12]\]. The allele frequencies might be different in various ethnicities; therefore, the risk genotype would be changeable in different ethnicities. The risk effect of the f allele of FokI was not found in the African population, which may be explained by the different f allele frequency in this population (0.192), while the f allele frequency of FokI was 0.442 in Asia ([[http://hapmap.ncbi.nlm.nih.gov/]{.ul}](http://hapmap.ncbi.nlm.nih.gov/)). Also, due to the small sample size, the analysis of the effect of the FokI polymorphism on tuberculosis was underpowered.

The ApaI and BsmI polymorphisms were located in the intron region between exon 8 and exon 9 of the VDR gene. Although the nucleotide changes of the ApaI and BsmI polymorphisms generated no changes in the amino acid or the structure of the expressed VDR protein, they might be in linkage disequilibrium with other functional polymorphisms which regulated VDR gene expression. Earlier studies have provided evidence of differential luciferase activity for the two 3\' UTR variants that were linked to the most frequent haplotypes \[[@B42]\]. In this meta-analysis, homozygote for the variant allele of the ApaI polymorphism ad heterozygote for the BsmI polymorphism both appeared to have a protective role on tuberculosis development in European population. However, due to the small sample size of the enrolled studies, this result needed to be validated in a larger European population.

The allele changes of the TaqI SNP would not generate an amino acid transformation. The t allele of the TaqI SNP seemed to be protective for tuberculosis in the African population, although the results were only marginally significant. This different might be explained by different ethnic backgrounds. The t allele frequency (HapMap data) of TaqI was 0.012 in the Chinese population and 0.118 in the Japanese population, 0.288 in the African population and 0.438 in the European population. Meanwhile, It has been suggested that the mRNA coded from the TaqI t allele of the VDR gene would be more stable than the mRNA from the T allele of the VDR gene \[[@B43]\], and a previous study revealed that the TaqI SNP in exon 9 near 3′ UTR was in linkage disequilibrium with the ApaI and BsmI polymorphisms \[[@B44]\], which may explain the same protective effect by the two variant alleles of the TaqI and BsmI polymorphisms on tuberculosis.

Finally, some limitations of this study need to be addressed. First, HIV status might influence tuberculosis incidence; so, the stratification of HIV status would further reveal the relationship between VDR gene SNPs and tuberculosis. However, HIV status was not reported in one-third of the enrolled studies. Therefore, it was not possible to apply stratification according to HIV status. Second, subgroup analysis with a small number of studies would reduce the statistical power of the analysis. Third, the main method for tuberculosis diagnosis was based on bacteriology. However, these bacteriological methods could not distinguish between *Mycobacterium tuberculosis* and *non-tuberculosis Mycobacterium* (*non-tuberculosis Mycobacterium* constituted a small portion of the clinical cases), which might exert a confounding effect.

In conclusion, this meta-analysis study evaluated the relationship between the VDR gene hot spot SNPs and the risk of tuberculosis in twenty-nine case-control studies, and provided evidence that the FokI SNP might increase the risk of tuberculosis in a recessive model. Thus, host genetic susceptibility might be involved in tuberculosis development. However, due to the small sample sizes, conclusions could not be drawn regarding the putative protective effect of the BsmI variant allele in the European population. Studies with larger sample sizes studies are warranted to be undertaken.
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